Biolife Solutions (BLFS) Operating Leases (2019 - 2026)

Biolife Solutions (BLFS) has reported Operating Leases for 8 consecutive years, with $15.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases rose 14.34% year-over-year to $15.7 million in Q2 2026; TTM through Jun 2026 was $15.7 million, a 14.34% increase from a year earlier, with the FY2025 full-year figure at $10.7 million, down 15.72% from the prior year.
• Operating Leases was $15.7 million for Q2 2026 at Biolife Solutions, up from $12.4 million in the prior quarter.
• Over five years, Operating Leases peaked at $18.7 million in Q1 2022 and troughed at $8.7 million in Q4 2023.
• A 5-year average of $14.9 million and a median of $15.1 million in 2022 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases jumped 74.0% in 2022 and tumbled 41.89% in 2023, its largest moves.
• Over 5 years, Operating Leases stood at $15.0 million in 2022, then slumped by 41.89% to $8.7 million in 2023, then surged by 45.43% to $12.6 million in 2024, then retreated by 15.72% to $10.7 million in 2025, then soared by 47.68% to $15.7 million in 2026.
• The last three Operating Leases figures came in at $15.7 million (Q2 2026), $12.4 million (Q1 2026), and $10.7 million (Q4 2025), per Business Quant data.